Obbligazioni societarie HIGH YIELD e oltre, verso frontiere inesplorate - Vol. 2 (6 lettori)

marcob77

Moderator
io ho la Jaguar 2026 in € e non penso che sia garantita da Tata a cascata delle scatole cinesi, comunque la tengo
Nel prospetto c'è proprio un disegno con
La ritengo un ottimo HY sono ben 2 marchi prestigiosi e di LandRovet in giro ne vedo tante e sono pure belle se poi si considera che sono in euro le tengo e se non fosse per il taglio accumulerei
pensi che a questi prezzi sia ancora buona? io stamattina avevo messo in acquisto a 91,2 ma non sono stato servito...poi è volata via..
 

policeman

Forumer storico
di alliance one si hanno notizie?
sempre down,hanno cambiato nome :pYXUS
non preoccuparti,sono i piu' grandi produttori nell'mondo di tabacco Leaves,forniscono i grandi produttori di sigarette.purtroppo non si sa come andra a finire la
storia delle cannabis che hanno comminciato a produrre in Canada
 

waltermasoni

Caribbean Trader
ma poi, a parte l'accordo di pagamento in USA, i conti come vanno?


Benissimo :d:



Teva Pharmaceutical Industries Ltd. Ratings Placed On CreditWatch Negative Following Opioid Settlement Framework

  • 24-Oct-2019 17:21 EDT
View Analyst Contact Information
  • Table of Contents
  • Israel-headquartered global specialty and generic pharmaceutical manufacturer Teva Pharmaceutical Industries Ltd. recently announced a tentative framework to settle litigation claims related to opioid sales for $23 billion of products and $250 million of cash over 10 years.
  • The cash cost of this settlement framework is uncertain, although we currently estimate the discounted cost as less than $2 billion and we believe the final agreement could require a higher cash contribution to satisfy a larger group of plaintiffs.
  • We are placing our ratings on Teva on CreditWatch with negative implications, including our 'BB' long-term issuer credit and senior unsecured issue-level ratings.
  • We will resolve the CreditWatch placements when we gain greater confidence as to whether the discounted cost will likely exceed $2 billion (our trigger for a lower rating).

NEW YORK (S&P Global Ratings) Oct. 24, 2019--S&P Global Ratings today took the rating actions listed above.

Our CreditWatch placements reflect the higher risk of a downgrade due to the significant cash cost from the proposed global settlement framework related to opioid litigation. The proposed settlement framework calls for Teva Pharmaceutical Industries Ltd. to provide up to approximately $23 billion of buprenorphine naloxone (sublingual tablets) and $250 million of cash, both over 10 years. We believe the final amount to settle all claims related to opioids is uncertain, but we estimate the tax-adjusted discounted cash liability of the proposed framework could total less than $2 billion, depending on the cost of supplying the buprenorphine naloxone and the actual demand in the U.S. for it. We estimate the annual cash cost to fulfill the proposed settlement framework will be in the $250 million-$400 million range.

We plan to resolve the CreditWatch placements when we have more certainty that the ultimate settlement to resolve the opioid claims will be more or less than about $2 billion. We could consider resolving the placements when Teva reports its reserve to account for its proposed settlement framework, if it materially exceeds $2 billion. Alternatively, we could consider resolving them when more plaintiffs agree to the proposed settlement agreement and we believe the ultimate liability will be less than roughly $2 billion. We expect this to occur in the next four to six months.

We will also evaluate the impact to our recovery ratings when a more concrete settlement agreement is known. We do not expect a lower senior unsecured rating, but we could consider revising the recovery rating if we believe the claim from a settlement would materially impair the recovery of lenders in a default scenario.
 

corradotedeschi

Forumer storico
sempre down,hanno cambiato nome :pYXUS
non preoccuparti,sono i piu' grandi produttori nell'mondo di tabacco Leaves,forniscono i grandi produttori di sigarette.purtroppo non si sa come andra a finire la
storia delle cannabis che hanno comminciato a produrre in Canada

Forse prima di dare degli ok di acquisti a chicchesia...bisognerebbe conoscere bene l'azienda...hanno fatto bilanci falsi e sono stati inquisiti in usa...quindi di questa azienda finanziariamente si sa quello che vogliono farci credere....e ormai le ho in carico ma appena passano il mio pmc vendo e salvo 200k...di cedole ne ho gia' prese x 3 anni...
 

Users who are viewing this thread

Alto